1. Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
- Author
-
Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, and De Jager PL
- Subjects
- Adult, Autoimmune Diseases of the Nervous System diagnosis, COVID-19 diagnosis, Cohort Studies, Female, Humans, Male, Middle Aged, Multiple Sclerosis diagnosis, Multiple Sclerosis epidemiology, Multiple Sclerosis psychology, Nervous System Diseases diagnosis, Nervous System Diseases epidemiology, Nervous System Diseases psychology, Pandemics, Prospective Studies, Autoimmune Diseases of the Nervous System epidemiology, Autoimmune Diseases of the Nervous System psychology, COVID-19 epidemiology, COVID-19 psychology, Self Report
- Abstract
Objective: To report initial results of a planned multicenter year-long prospective study examining the risk and impact of COVID-19 among persons with neuroinflammatory disorders (NID), particularly multiple sclerosis (MS)., Methods: In April 2020, we deployed online questionnaires to individuals in their home environment to assess the prevalence and potential risk factors of suspected COVID-19 in persons with NID (PwNID) and change in their neurological care., Results: Our cohort included 1115 participants (630 NID, 98% MS; 485 reference) as of 30 April 2020. 202 (18%) participants, residing in areas with high COVID-19 case prevalence, met the April 2020 CDC symptom criteria for suspected COVID-19, but only 4% of all participants received testing given testing shortages. Among all participants, those with suspected COVID-19 were younger, more racially diverse, and reported more depression and liver disease. PwNID had the same rate of suspected COVID-19 as the reference group. Early changes in disease management included telemedicine visits in 21% and treatment changes in 9% of PwNID. After adjusting for potential confounders, increasing neurological disability was associated with a greater likelihood of suspected COVID-19 (OR
adj = 1.45, 1.17-1.84)., Interpretations: Our study of real-time, patient-reported experience during the COVID-19 pandemic complements physician-reported MS case registries which capture an excess of severe cases. Overall, PwNID seem to have a risk of suspected COVID-19 similar to the reference population., (© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)- Published
- 2021
- Full Text
- View/download PDF